The Challenge of Return to Work after Breast Cancer: The Role of Family Situation, CANTO Cohort.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
01 10 2021
Historique:
received: 14 09 2021
revised: 27 09 2021
accepted: 29 09 2021
entrez: 22 10 2021
pubmed: 23 10 2021
medline: 28 10 2021
Statut: epublish

Résumé

Return to work (RTW) after breast cancer is associated with improved quality of life. The link between household characteristics and RTW remains largely unknown. The aim of this study was to examine the effect of the family situation on women's RTW two years after breast cancer. We used data of a French prospective cohort of women diagnosed with stage I-III, primary breast cancer (CANTO, NCT01993498). Among women employed at diagnosis and under 57 years old, we assessed the association between household characteristics (living with a partner, marital status, number and age of economically dependent children, support by the partner) and RTW. Logistic regression models were adjusted for age, household income, stage, comorbidities, treatments and their side effects. Analyzes stratified by age and household income were performed to assess the association between household characteristics and RTW in specific subgroups. Among the 3004 patients included, women living with a partner returned less to work (OR = 0.63 [0.47-0.86]) and decreased their working time after RTW. Among the 2305 women living with a partner, being married was associated with decreased RTW among women aged over 50 (OR = 0.57 [0.34-0.95]). Having three or more children (vs. none) was associated with lower RTW among women with low household income (OR = 0.28 [0.10-0.80]). Household characteristics should be considered in addition to clinical information to identify vulnerable women, reduce the social consequence of cancer and improve their quality of life.

Identifiants

pubmed: 34677248
pii: curroncol28050330
doi: 10.3390/curroncol28050330
pmc: PMC8534983
doi:

Banques de données

ClinicalTrials.gov
['NCT01993498']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3866-3875

Subventions

Organisme : French Foundation for Cancer Research
ID : PGA1 RF20170205420
Organisme : Susan G. Komen Career Catalyst Research
ID : CCR17483507
Organisme : French Government under the Investment for the Future program managed by the National Research Agency
ID : ANR-10-COHO0004

Références

Support Care Cancer. 2015 Mar;23(3):889-98
pubmed: 25337681
Cancer. 2013 Jun 1;119 Suppl 11:2151-9
pubmed: 23695927
Acta Oncol. 2007;46(1):90-6
pubmed: 17438710
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Nurs Scholarsh. 2016 Jan;48(1):39-47
pubmed: 26580861
Eur J Cancer Care (Engl). 2014 Mar;23(2):274-83
pubmed: 24237363
J Occup Rehabil. 2017 Dec;27(4):547-558
pubmed: 27858198
BMC Health Serv Res. 2018 Dec 29;18(1):1000
pubmed: 30594181
J Cancer Surviv. 2021 May 5;:
pubmed: 33950477
Sociol Health Illn. 2015 Sep;37(7):1086-101
pubmed: 25922881
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Eur J Oncol Nurs. 2011 Jul;15(3):267-74
pubmed: 21478053
Soc Sci Med. 2016 Feb;151:121-9
pubmed: 26802368
J Cancer Surviv. 2020 Apr;14(2):114-134
pubmed: 31858379
Eur J Cancer Care (Engl). 2019 Jul;28(4):e13051
pubmed: 31033073
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Cancer Surviv. 2020 Apr;14(2):135-150
pubmed: 32162193
Cancer. 2018 Dec 15;124(24):4700-4710
pubmed: 30329152
Cancer. 2018 May 1;124(9):2026-2035
pubmed: 29437204
Scand J Work Environ Health. 2012 Mar;38(2):144-54
pubmed: 21986836
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Clin Oncol. 2006 Jan 20;24(3):345-53
pubmed: 16421415
J Clin Oncol. 2018 Jun 20;36(18):1868-1879
pubmed: 29757686
N Engl J Med. 2017 Jul 13;377(2):122-131
pubmed: 28581356
Int J Mol Sci. 2020 Feb 18;21(4):
pubmed: 32085669
Health Qual Life Outcomes. 2016 Jun 07;14:87
pubmed: 27267486
Work. 2018;61(3):463-476
pubmed: 30400123
Disabil Rehabil. 2017 Oct;39(21):2164-2172
pubmed: 27596990
Acta Oncol. 2013 Feb;52(2):423-9
pubmed: 23282112
Cancer. 1990 Feb 1;65(3 Suppl):742-51
pubmed: 2105832
J Clin Oncol. 2020 Mar 1;38(7):734-743
pubmed: 31834818
J Occup Rehabil. 2010 Mar;20(1):49-58
pubmed: 19902340

Auteurs

Elsa Caumette (E)

IPLESP, Équipe de Recherche en Épidémiologie Sociale, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Sorbonne Université, 75012 Paris, France.
Department of maieutics, University of Montpellier, 34000 Montpellier, France.

Inès Vaz-Luis (I)

Breast Cancer Unit, Department of Medical Oncology, Gustave Roussy, 94800 Villejuif, France.
INSERM Unit U 981, Gustave Roussy, 94800 Villejuif, France.

Sandrine Pinto (S)

IPLESP, Équipe de Recherche en Épidémiologie Sociale, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Sorbonne Université, 75012 Paris, France.

Julie Havas (J)

INSERM Unit U 981, Gustave Roussy, 94800 Villejuif, France.
Clinical Research Department, Gustave Roussy, 94800 Villejuif, France.

Thomas Bovagnet (T)

IPLESP, Équipe de Recherche en Épidémiologie Sociale, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Sorbonne Université, 75012 Paris, France.

Garazi Ruiz de Azua (G)

IPLESP, Équipe de Recherche en Épidémiologie Sociale, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Sorbonne Université, 75012 Paris, France.

Antonio Di Meglio (A)

INSERM Unit U 981, Gustave Roussy, 94800 Villejuif, France.

Anne-Laure Martin (AL)

UNICANCER, 75013 Paris, France.

Sibille Everhard (S)

UNICANCER, 75013 Paris, France.

Paul Cottu (P)

Institute Curie, 75005 Paris, France.

Laurence Vanlemmens (L)

Center Oscar Lambret, 59000 Lille, France.

Christelle Jouannaud (C)

Institute Jean Godinot, 51100 Reims, France.

Florence Lerebours (F)

Institute Curie, 92210 Saint Cloud, France.

Agnès Dumas (A)

ECEVE UMR 1123, INSERM (National Institute for Health and Medical Research), Université de Paris, 75010 Paris, France.

Gwenn Menvielle (G)

IPLESP, Équipe de Recherche en Épidémiologie Sociale, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Sorbonne Université, 75012 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH